GlassScriptPhysician profile
Vicki Miller
NPI 1548283088
$2,028.57
in general payments reported to CMS, 2019-2025
27 companies · $444 in 2025
The $444 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $171 · 2021: $266 · 2022: $158 · 2023: $237 · 2024: $228 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.35 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $362.93 | 2019-2023 | |
| Astellas Pharma US INC | $279.90 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $193.63 | 2019-2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $168.04 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $154.80 | 2019-2024 | Aptima |
| Myovant Sciences INC. | $122.06 | 2021 | |
| Medical Device Business Services, INC. | $116.75 | 2019 | |
| Organon LLC | $85.86 | 2022-2025 | Nexplanon |
| Exact Sciences Corporation | $66.06 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $49.53 | 2022-2024 | |
| Channel Medsystems, INC. | $47.16 | 2023 | |
| Exeltis, USA INC. | $43.79 | 2019-2024 | Slynd |
| Mayne Pharma Commercial LLC | $36.99 | 2023-2025 | |
| Optumhealth Care Solutions, LLC | $36.74 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Agile Therapeutics, INC. | $35.48 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $34.89 | 2019 | |
| Aspira Women'S Health INC | $33.66 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.07 | 2022-2024 | |
| Becton, Dickinson and Company | $20.47 | 2024 | Bd Onclarity |
| Shield Therapeutics INC | $16.57 | 2025 | |
| Amag Pharmaceuticals, INC. | $14.97 | 2020 | |
| Evofem Biosciences, INC. | $14.85 | 2021 | |
| Therapeuticsmd, INC. | $14.05 | 2022 | |
| Minerva Surgical, INC | $13.96 | 2025 | |
| Allergan, INC. | $12.09 | 2020 | |
| Avion Pharmaceuticals | $12.07 | 2019 | |
| Merck Sharp & Dohme LLC | $11.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicki Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.